01558 HEC CJ PHARM
Closed Add to Porfolio| Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind | |||
| Major Shareholders | Sunshine Lake Pharma Co., Ltd. (51.41%) | Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.hec-changjiang.com | Tel | (86 769) 8176-8866 |
| changjiangpharm@dyg-hec.com | Fax | N/A | |
| Related Equities | N/A | ||
| Principal Activities | The Company is a PRC pharmaceutical manufacturing company that focuses on the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases and cardiovascular diseases. | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|---|---|---|
| SCHWARZMAN Stephen A. | 82,631,578(L) | 36.59(L) | 20/02/2019 |
| Blackstone Tactical Opportunities LR Associates (Cayman) – NQ Ltd. | 82,166,775(L) | 36.38(L) | 20/02/2019 |
| 毛杰 | 81,456,400(L) 75,000,000(S) | 36.07(L) 33.21(S) | 31/12/2018 |
| Ningbo Sanxing Medical Electric Co., Ltd. | 13,480,400(L) | 5.97(L) | 15/08/2018 |
| 何意菊 | 13,480,400(L) | 5.97(L) | 15/08/2018 |
| 鄭堅江 | 13,480,400(L) | 5.97(L) | 15/08/2018 |
| Morgan Stanley | 11,310,838(L) 160,954(S) 0(P) | 5.00(L) 0.07(S) 0.00(P) | 22/02/2019 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|---|---|---|
| 唐新发 | 65,200(L) | 0.02(L) | 17/01/2019 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
